Pamidronate therapy for hypercalcemia and congenital mesoblastic nephroma: a case report
-
* Corresponding author: Amir Hosein Davarpanah Jazi davarpanah@edc.mui.ac.ir
1 Department of Pediatric Endocrinology, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Pediatric Surgery, Isfahan University of Medical Sciences, Isfahan, Iran
3 Medical Education Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Cases Journal 2009, 2:9315 doi:10.1186/1757-1626-2-9315
Published: 12 December 2009Abstract
Hypercalcemia can causes life threatening complications. We report an infant with severe hypercalcemia due to congenital mesoblastic nephroma. Hypercalcemia was corrected before nephrectomy by pamidronate. According to our knowledge this is a rare case with severe neoplasm induced hypercalcemia among neonates who treated by bisphosphonates. The aim of this report is to define new approach to neoplasm induced neonatal hypercalcemia.